Results 1 to 10 of about 1,050,694 (335)

Minor Adverse Events Postcolonoscopy [PDF]

Canadian Journal of Gastroenterology and Hepatology, 2014
In recent years, the Canadian Journal of Gastroenterology and Hepatology has provided its readership with multiple publications to further our understanding of what constitutes a high-quality procedure as well as a desirable colonoscopy experience (1–4).
Catherine Dubé
doaj   +3 more sources

Adverse Events of DOACs in Children

Frontiers in Pediatrics, 2022
Venous thromboembolism (VTE) has an increasing rate of significance in pediatric patients. The currently standardized anticoagulants (unfractionated heparin, low molecular weight heparin and vitamin K antagonists) and their dose regimens were not ...
Alessandra Bosch, Manuela Albisetti, Manuela Albisetti   +2 more
doaj   +3 more sources

Postmarketing Surveillance of Full Spectrum Hemp Extract CBD Products: Reported Adverse Events and Serious Adverse Events [PDF]

Drugs - Real World Outcomes
Background There is a growing interest in products featuring hemp extracts and a demand for more data regarding their safety. To date, there is a paucity of published data on the safety of these products. Methods A retrospective analysis of postmarketing
Colleen M. Kingsbury, Ivori Zvorsky, Kevin Spelman   +2 more
doaj   +2 more sources

Evaluating adverse events in databases

Pharmacology Research & Perspectives, 2023
Katie Lovell, Steven R. Feldman
doaj   +3 more sources

High-Antimicrobial Gallium-Doped Zinc Oxide Thin Films on Bio-Based Poly(Ethylene Furanoate) Substrates for Food Packaging Application

Membranes, 2023
Thin films of gallium-doped zinc oxide (GZO), with a thickness of around fifty nanometers were deposited on bio-based poly(ethylene furanoate) (PEF) substrates by radio-frequency sputtering.
Chaoting Zhu, Danling Ye, Tianqi Zhou, Yashuang Cui, Jianbing Yin   +4 more
doaj   +1 more source

Adverse events: an expensive and avoidable hospital problem

Annals of Medicine, 2022
Introduction Adverse healthcare-related events (AE) entail reduced patient safety. Estimating their frequency, characteristics, avoidability and impact is a means to identify targets for improvement in the quality of care.Methods This was a descriptive ...
Diego San Jose-Saras, José L. Valencia-Martín, Jorge Vicente-Guijarro, Paloma Moreno-Nunez, Alberto Pardo-Hernández, Jesús M. Aranaz-Andres   +5 more
doaj   +1 more source

Bio-based poly(ethylene furanoate)/ZnO transparent thin films with improved water vapor barrier and antibacterial properties for food packaging application

Materials Research Express, 2022
Poly(ethylene furanoate) (PEF) biocomposite films incorporating zinc oxide nanoparticle (ZnO NPs) were prepared using a solvent casting method. The ZnO NPs were homogeneously dispersed within the PEF films with the aid of γ −aminopropyltriethoxylsilane ...
Chaoting Zhu, Jianbing Yin, Zhilong Zhang, Feng Shi   +3 more
doaj   +1 more source

IL12/23 Blockade with Ustekinumab as a Treatment for Immune-Related Cutaneous Adverse Events

Pharmaceuticals, 2023
Background: Immune-related cutaneous adverse events (ircAEs) are frequent and may reduce quality of life and consistent dosing. IL12/23 has been implicated in psoriasis, which is reminiscent of the psoriasiform/lichenoid ircAE phenotype.
Stephanie L. Gu, Tara Maier, Andrea P. Moy, Stephen Dusza, David M. Faleck, Neil J. Shah, Mario E. Lacouture   +6 more
doaj   +1 more source

Adverse events [PDF]

American Journal of Orthodontics and Dentofacial Orthopedics, 2017
Any medical intervention generates modifications in the homeostasis of the treated organism. The effect in most cases is not apparent at the clinical level; when manifested, it may be inherent to the expected therapeutic action or associate as a side effect expressed in a multiplicity of epiphenomena with different physiognomy and capacity of altering ...
openaire   +4 more sources

Overlap between adverse events (AEs) and serious adverse events (SAEs): a case study of a phase III cancer clinical trial

Trials, 2020
Background Safety data is required to be collected in all clinical trials and can be separated into two types of data, adverse events and serious adverse events.
Elizabeth C. James, David Dunn, Adrian D. Cook, Andrew R. Clamp, Matthew R. Sydes   +4 more
doaj   +1 more source